SCHEMBL8404564

SCHEMBL8404564

O=C1Nc2ccccc2N2CCC3CC(C3)CC12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.67
KDM4E B2RXH2 3/20 0.67
MAPT P10636 3/20 0.67
GAA P10253 2/20 0.67
KMT2A Q03164 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
OPRM1 P35372 2/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
OGFRL1 Q5TC84 1/20 0.41
MEN1 O00255 3/20 0.40
PARP1 P09874 4/20 0.40
HTR2C P28335 2/20 0.39
HPGD P15428 2/20 0.39
CHEK1 O14757 1/20 0.39
MAP2K1 Q02750 1/20 0.39
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CHRM2 P08172 1/20 0.37
DDB1 Q16531 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38658291 0.84 ALDH1A1 (0.65) ALDH1A1KDM4EMAPTGAAKMT2A
SCHEMBL7968278 0.80 ALDH1A1 (1.00) ALDH1A1KDM4EMAPTGAAKMT2A
SCHEMBL7981536 0.80 ALDH1A1 (1.00) ALDH1A1KDM4EMAPTGAAKMT2A
SCHEMBL10502579 0.80 ALDH1A1 (1.00) ALDH1A1KDM4EMAPTGAAKMT2A
SCHEMBL8080267 0.79 ALDH1A1 (0.91) ALDH1A1KDM4EMAPTGAAKMT2A
SCHEMBL15523572 0.78 GAA (0.88) ALDH1A1KDM4EMAPTGAAKMT2A
SCHEMBL31343832 0.77 ALDH1A1 (0.55) ALDH1A1KDM4EMAPTGAAKMT2A
SCHEMBL31343855 0.77 ALDH1A1 (0.55) ALDH1A1KDM4EMAPTGAAKMT2A
SCHEMBL25045478 0.75 HTR2C (0.67) ALDH1A1KDM4EMAPTGAASMN1; SMN2
SCHEMBL7981338 0.75 KDM4E (0.56) ALDH1A1KDM4EMAPTGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790721-B2 Pyrroloquinoxalinone inhibitors of poly(ADP-ribose)polymerase ABBOTT LABORATORIES (US) 2010-09-07 US disclosed
US-20080161292-A1 INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE ABBOTT LABORATORIES (US) 2008-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161292-A1 INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE PARP1, PARP2, PARP3 ALDH1A1 1358/4885KDM4E 4026/4885MAPT 3017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.